Clinical Trial Update: Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo [Phase 3]

View source ↗

Summary

Phase 3 trial updating neoadjuvant chemotherapy with atezolizumab or placebo in triple-negative breast cancer, followed by atezolizumab or placebo post-surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Triple Negative Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING